Page last updated: 2024-08-25

bexarotene and Acute Relapsing Multiple Sclerosis

bexarotene has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Altmann, DR; Brown, JWL; Chandran, S; Chard, DT; Coles, AJ; Connick, P; Cunniffe, NG; Ffrench-Constant, C; Flynn, PD; Franklin, RJM; Gandini Wheeler-Kingshott, CAM; Georgieva, Z; Jones, JL; Kanber, B; MacManus, D; Michell, AW; Moran, C; Needham, E; Overell, J; Pearson, OR; Prados, F; Rog, D; Samson, RS; Stutters, J	1

Trials

1 trial(s) available for bexarotene and Acute Relapsing Multiple Sclerosis

Article	Year
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. The Lancet. Neurology, 2021, Volume: 20, Issue:9 Topics: Adult; Bexarotene; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Outcome Assessment, Health Care; Remyelination; Retinoid X Receptors	2021

Article

Year

Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study.

The Lancet. Neurology, 2021, Volume: 20, Issue:9

Topics: Adult; Bexarotene; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Outcome Assessment, Health Care; Remyelination; Retinoid X Receptors

2021